§ Dr. StoateTo ask the Secretary of State for Health if Campath has received approval from the National Institute for Clinical Excellence; what plans he has to increase its availability to NHS patients; and if he will make a statement. [1417]
§ Yvette CooperAlemtuzumab (Campath, Berlex Laboratories) is not currently licensed for use in the United Kingdom and has not been considered for the institute's work programme.